PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7642544-0	1995	Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor.	Serine	75-81	NFKB inhibitor alpha	Homo sapiens	59-74	
7642544-0	1995	Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor.	Serine	75-81	nuclear factor kappa B subunit 1	Homo sapiens	101-123	
7642544-0	1995	Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor.	Serine	75-81	tumor necrosis factor	Homo sapiens	138-159	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	pervanadate	51-62	tumor necrosis factor	Homo sapiens	96-117	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	pervanadate	51-62	tumor necrosis factor	Homo sapiens	119-122	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	pervanadate	51-62	nuclear factor kappa B subunit 1	Homo sapiens	132-154	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	pervanadate	51-62	nuclear factor kappa B subunit 1	Homo sapiens	156-166	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	oxophenylarsine	67-85	tumor necrosis factor	Homo sapiens	96-117	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	oxophenylarsine	67-85	tumor necrosis factor	Homo sapiens	119-122	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	oxophenylarsine	67-85	nuclear factor kappa B subunit 1	Homo sapiens	132-154	
7642544-1	1995	Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF).	oxophenylarsine	67-85	nuclear factor kappa B subunit 1	Homo sapiens	156-166	
7642544-2	1995	The inhibitors also abrogate NF-kappa B activation by the phosphoseryl/threonyl protein phosphatase inhibitor okadaic acid in U-937 cells.	Okadaic Acid	110-122	nuclear factor kappa B subunit 1	Homo sapiens	29-39	
7642544-6	1995	Conversely, treatment of human protein-tyrosine phosphatase alpha-overexpressing cells with phenylarsine oxide led to a loss of the constitutive NF-kappa B activity.	oxophenylarsine	92-110	nuclear factor kappa B subunit 1	Homo sapiens	145-155	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	18-26	nuclear factor kappa B subunit 1	Homo sapiens	68-78	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	18-26	NFKB inhibitor alpha	Homo sapiens	80-95	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	18-26	tumor necrosis factor	Homo sapiens	137-140	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Okadaic Acid	141-153	nuclear factor kappa B subunit 1	Homo sapiens	68-78	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Okadaic Acid	141-153	NFKB inhibitor alpha	Homo sapiens	80-95	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Okadaic Acid	141-153	tumor necrosis factor	Homo sapiens	137-140	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	162-170	nuclear factor kappa B subunit 1	Homo sapiens	68-78	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	162-170	NFKB inhibitor alpha	Homo sapiens	80-95	
7642544-7	1995	The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation.	Tyrosine	162-170	tumor necrosis factor	Homo sapiens	137-140	
7642544-8	1995	However, no tyrosine phosphorylation was detected on I kappa B-alpha fron unstimulated cells, while TNF/okadaic acid-treated cells showed increased phosphorylation of I kappa B-alpha exclusively at serine residue(s).	Okadaic Acid	104-116	tumor necrosis factor	Homo sapiens	100-103	
7642544-8	1995	However, no tyrosine phosphorylation was detected on I kappa B-alpha fron unstimulated cells, while TNF/okadaic acid-treated cells showed increased phosphorylation of I kappa B-alpha exclusively at serine residue(s).	Okadaic Acid	104-116	NFKB inhibitor alpha	Homo sapiens	167-182	
7642544-8	1995	However, no tyrosine phosphorylation was detected on I kappa B-alpha fron unstimulated cells, while TNF/okadaic acid-treated cells showed increased phosphorylation of I kappa B-alpha exclusively at serine residue(s).	Serine	198-204	tumor necrosis factor	Homo sapiens	100-103	
7642544-8	1995	However, no tyrosine phosphorylation was detected on I kappa B-alpha fron unstimulated cells, while TNF/okadaic acid-treated cells showed increased phosphorylation of I kappa B-alpha exclusively at serine residue(s).	Serine	198-204	NFKB inhibitor alpha	Homo sapiens	167-182	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	tumor necrosis factor	Homo sapiens	46-49	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	NFKB inhibitor alpha	Homo sapiens	58-73	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	tumor necrosis factor	Homo sapiens	243-246	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	NFKB inhibitor alpha	Homo sapiens	255-270	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	nuclear factor kappa B subunit 1	Homo sapiens	287-297	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	tumor necrosis factor	Homo sapiens	243-246	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	pervanadate	24-35	NFKB inhibitor alpha	Homo sapiens	255-270	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	n alpha-p-tosyl-l-lysine chloromethyl ketone	188-232	tumor necrosis factor	Homo sapiens	243-246	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	n alpha-p-tosyl-l-lysine chloromethyl ketone	188-232	NFKB inhibitor alpha	Homo sapiens	255-270	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	n alpha-p-tosyl-l-lysine chloromethyl ketone	188-232	nuclear factor kappa B subunit 1	Homo sapiens	287-297	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	n alpha-p-tosyl-l-lysine chloromethyl ketone	188-232	tumor necrosis factor	Homo sapiens	243-246	
7642544-9	1995	Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha.	n alpha-p-tosyl-l-lysine chloromethyl ketone	188-232	NFKB inhibitor alpha	Homo sapiens	255-270	
7642544-10	1995	The data suggest that TNF and okadaic acid induce the activation of a putative protein-tyrosine phosphatase(s), leading to I kappa B-alpha serine phosphorylation and degradation and NF-kappa B nuclear translocation.	Okadaic Acid	30-42	NFKB inhibitor alpha	Homo sapiens	123-138	
7642544-10	1995	The data suggest that TNF and okadaic acid induce the activation of a putative protein-tyrosine phosphatase(s), leading to I kappa B-alpha serine phosphorylation and degradation and NF-kappa B nuclear translocation.	Okadaic Acid	30-42	nuclear factor kappa B subunit 1	Homo sapiens	182-192	
7642544-10	1995	The data suggest that TNF and okadaic acid induce the activation of a putative protein-tyrosine phosphatase(s), leading to I kappa B-alpha serine phosphorylation and degradation and NF-kappa B nuclear translocation.	Serine	139-145	tumor necrosis factor	Homo sapiens	22-25	
7642544-10	1995	The data suggest that TNF and okadaic acid induce the activation of a putative protein-tyrosine phosphatase(s), leading to I kappa B-alpha serine phosphorylation and degradation and NF-kappa B nuclear translocation.	Serine	139-145	NFKB inhibitor alpha	Homo sapiens	123-138